CU20180036A7 - THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS - Google Patents
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUSInfo
- Publication number
- CU20180036A7 CU20180036A7 CUP2018000036A CU20180036A CU20180036A7 CU 20180036 A7 CU20180036 A7 CU 20180036A7 CU P2018000036 A CUP2018000036 A CU P2018000036A CU 20180036 A CU20180036 A CU 20180036A CU 20180036 A7 CU20180036 A7 CU 20180036A7
- Authority
- CU
- Cuba
- Prior art keywords
- treatment
- immunodeficiency virus
- human immunodeficiency
- therapeutic compositions
- pharmaceutically acceptable
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960000366 emtricitabine Drugs 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- LDEKQSIMHVQZJK-CAQYMETFSA-N tenofovir alafenamide Chemical compound O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1 LDEKQSIMHVQZJK-CAQYMETFSA-N 0.000 abstract 1
- 229960004946 tenofovir alafenamide Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<p>Se proporciona una forma de dosificación oral sólida, que comprende un compuesto de Fórmula I o una sal farmacéuticamente aceptable del mismo, tenofovir alafenamida o una sal farmacéuticamente aceptable de Ia misma, y emtricitabina o una sal farmacéuticamente aceptable de Ia misma.</p><p> A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof. < / p>
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562253042P | 2015-11-09 | 2015-11-09 | |
| US201662339999P | 2016-09-26 | 2016-09-26 | |
| PCT/US2016/060989 WO2017083304A1 (en) | 2015-11-09 | 2016-11-08 | Therapeutic compositions for treatment of human immunodeficiency virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20180036A7 true CU20180036A7 (en) | 2018-07-05 |
Family
ID=62748490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CUP2018000036A CU20180036A7 (en) | 2015-11-09 | 2016-11-08 | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20180036A7 (en) |
-
2016
- 2016-11-08 CU CUP2018000036A patent/CU20180036A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018001199A1 (en) | Therapeutic compositions for the treatment of human immunodeficiency virus | |
| CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
| CL2017003320A1 (en) | Pharmaceutical formulations containing tenofovir and emtricitabine | |
| CL2017000379A1 (en) | Pyrrolopyrimidine compounds used as toll receptor agonists. 7 (tlr7) | |
| EA201791256A1 (en) | HINAZOLIN DERIVATIVES USED FOR HIV TREATMENT | |
| EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
| DOP2016000254A (en) | PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE. | |
| CY1122077T1 (en) | NEW CYCLED PHENOXYACETAMIDIES | |
| ZA201607489B (en) | Combination comprising a glucocorticoid and edo-s101 | |
| CR20160527A (en) | CARBOXAMIDE DERIVATIVES | |
| EA201692111A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES | |
| BR112018006206A2 (en) | composition, use of a combination, pharmaceutical fixed dosage form, fixed dosage combination, packaging, and use of a fixed dose combination | |
| UY36123A (en) | CARBOXAMIDE DERIVATIVES | |
| EA201890929A1 (en) | LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE | |
| EA201790020A1 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| MX384394B (en) | COMPOUND FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES. | |
| JOP20200005A1 (en) | Pharmacy fixtures | |
| CU20180036A7 (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | |
| UY33806A (en) | NOVEDOUS IMIDAZOQUINOLINE COMPOUNDS, COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF DISEASES MEDIATED BY TLR7? | |
| EA201992754A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| AR106645A1 (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | |
| TN2016000479A1 (en) | Nitisinone dosing regimens for the treatment of alkaptonuria. | |
| UA112089C2 (en) | SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED |